Which of the following codes would apply to a patient admitted for chemotherapy for hepatocellular carcinoma?

• A. T86.49, C80.2, C22.0
• B. Z51.11, C22.0, C80.2
• C. C22.0
• D. C80.2

Answer: (B)

In this scenario, the accurate coding for a patient admitted for chemotherapy for hepatocellular carcinoma includes multiple components that reflect the patient's condition and treatment.

The code for hepatocellular carcinoma is essential for indicating the specific diagnosis; that is represented by C22.0. This signifies that the patient has liver cancer, which is critical for any documentation regarding the patient's health status and treatment plan.

Additionally, Z51.11 is used to denote a patient receiving chemotherapy. This code captures the intent of the admission, which is specifically for the treatment of cancer, indicating that the patient is in a state of active management aimed at addressing their diagnosed disease.

Finally, C80.2 is the code for unspecified malignant neoplasm, which may be used in conjunction when a more specific diagnosis like C22.0 is paired with the treatment code. This coding allows for full documentation of the patient's treatment while acknowledging the oncology context.

By using this combination of codes, it ensures thorough coverage of the patient's health condition and the specific nature of their treatment, which is crucial for billing purposes and for providing clear information in their medical records.